Detalles de la búsqueda
1.
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.
J Clin Oncol
; 23(25): 5900-9, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16043828
Resultados
1 -
1
de 1
1
Próxima >
>>